Literature DB >> 26195722

"Right-to-Try" Legislation: Progress or Peril?

Y Tony Yang1, Brian Chen2, Charles Bennett2.   

Abstract

Mesh:

Year:  2015        PMID: 26195722     DOI: 10.1200/JCO.2015.62.8057

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  7 in total

1.  Medical Negligence Determinations, the "Right to Try," and Expanded Access to Innovative Treatments.

Authors:  Denise Meyerson
Journal:  J Bioeth Inq       Date:  2017-06-20       Impact factor: 1.352

2.  Expanded Access of Investigational Drugs: The Experience of the Center of Drug Evaluation and Research Over a 10-Year Period.

Authors:  Jonathan P Jarow; Steven Lemery; Kevin Bugin; Sean Khozin; Richard Moscicki
Journal:  Ther Innov Regul Sci       Date:  2016-11       Impact factor: 1.778

3.  Expanding Patient Access to Investigational Drugs: Single Patient Investigational New Drug and the "Right to Try".

Authors:  Gail A Van Norman
Journal:  JACC Basic Transl Sci       Date:  2018-05-30

4.  "I Think It's Been Met With a Shrug:" Oncologists' Views Toward and Experiences With Right-to-Try.

Authors:  Cambray Smith; Jeremiah Stout; Alex A Adjei; Jan Buckner; Mark Wentworth; Jon Tilburt; Zubin Master
Journal:  J Natl Cancer Inst       Date:  2021-06-01       Impact factor: 13.506

5.  Going "social" to access experimental and potentially life-saving treatment: an assessment of the policy and online patient advocacy environment for expanded access.

Authors:  Tim K Mackey; Virginia J Schoenfeld
Journal:  BMC Med       Date:  2016-02-02       Impact factor: 8.775

6.  An analysis of common ethical justifications for compassionate use programs for experimental drugs.

Authors:  Kasper Raus
Journal:  BMC Med Ethics       Date:  2016-10-18       Impact factor: 2.652

7.  The significant cost of systematic reviews and meta-analyses: A call for greater involvement of machine learning to assess the promise of clinical trials.

Authors:  Matthew Michelson; Katja Reuter
Journal:  Contemp Clin Trials Commun       Date:  2019-08-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.